Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 07/10/2011
PIL Zomig Rapimelt 5 mg Orodispersible Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 16/12/2008 and displayed until 07/10/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to warnings or special precautions for use
Updated on 16/04/2008 and displayed until 16/12/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 27/02/2008 and displayed until 16/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 26/08/2005 and displayed until 27/02/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/02/2005 and displayed until 26/08/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  zolmitriptan